VALENCIA, Calif.--(BUSINESS WIRE)--MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at upcoming conferences.
The 14th Annual BioCEO Investor Conference on February 14, 2012 at 2:00 p.m. ET at the Waldorf-Astoria in New York, New York The Leerink Swann 2012 Global Healthcare Conference on February 15, 2012 at 9:00 a.m. ET at the Waldorf-Astoria in New York, New York
